GoAI
Get started
Data Horizon Corporation logo

Data Horizon Corporation

3628.T

JPXHealthcareMedical - Healthcare Information Services

Open in GoAI

Latest quote

¥599

+¥7.00 · +1.18%

Aug 24, 1:16 PM JSTData delayed

3628.T company overview

Regular session · JST · Market data may be delayed.

Company profile

Company website

Data Horizon Corporation offers specialized health data support solutions to insurance providers across Japan. The company develops and supplies medical information services, encompassing health-relevant data and notifications about generic drugs, alongside a comprehensive system designed to support health-related businesses. Founded in 1981, its headquarters are situated in Hiroshima, Japan. Data Horizon Corporation operates as a subsidiary of DeNA Co., Ltd.

Industry
Medical - Healthcare Information Services
Sector
Healthcare
Headquarters
JP
CEO
Sho Segawa
Listed since
Sep 19, 2008
Employees
365

Market position

Day range

Current ¥599

52-week range

Current ¥599

Open
¥599
Previous close
¥592
Volume
1.8K
0.06× average
Average volume
28.26K
Average daily volume
Market cap
7.6B JPY
Beta
0.14
Market reference 1
50-day average
¥554.6
+8.01% above average
200-day average
¥528.91
+13.25% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
10.61B JPY
EV / EBITDA
27.36×
Earnings yield
4.23%
Free cash flow yield
-4.89%

Profitability & efficiency

Return on equity
56.25%
Return on assets
3.21%
Return on invested capital
0.29%

Financial health

Current ratio
1.32×

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends61%11%-39%-89%Gross margin, FY2021: 48.25%Gross margin, FY2022: 26.81%Gross margin, FY2023: 37.95%Gross margin, FY2024: 40.37%Gross margin, FY2025: 34.76%Operating margin, FY2021: -10.56%Operating margin, FY2022: -11.30%Operating margin, FY2023: -15.75%Operating margin, FY2024: -13.40%Operating margin, FY2025: 0.45%Net margin, FY2021: -13.74%Net margin, FY2022: -15.07%Net margin, FY2023: -16.12%Net margin, FY2024: -76.93%Net margin, FY2025: 5.21%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 48.25%. Gross margin FY2022 26.81%. Gross margin FY2023 37.95%. Gross margin FY2024 40.37%. Gross margin FY2025 34.76%. Operating margin FY2021 -10.56%. Operating margin FY2022 -11.30%. Operating margin FY2023 -15.75%. Operating margin FY2024 -13.40%. Operating margin FY2025 0.45%. Net margin FY2021 -13.74%. Net margin FY2022 -15.07%. Net margin FY2023 -16.12%. Net margin FY2024 -76.93%. Net margin FY2025 5.21%.

Income trends

Revenue

5.14B JPY+0.07%

Operating income

22.94M JPY+711.29M JPY

Net income

268M JPY+4.22B JPY
Income trends across reported periods6.05B JPY2.41B JPY−1.22B JPY−4.86B JPYRevenue, FY2021: 2.99B JPYRevenue, FY2022: 4.41B JPYRevenue, FY2023: 5.01B JPYRevenue, FY2024: 5.14B JPYRevenue, FY2025: 5.14B JPYOperating income, FY2021: −315.91M JPYOperating income, FY2022: −498.5M JPYOperating income, FY2023: −788.47M JPYOperating income, FY2024: −688.35M JPYOperating income, FY2025: 22.94M JPYNet income, FY2021: −410.8M JPYNet income, FY2022: −664.86M JPYNet income, FY2023: −807.18M JPYNet income, FY2024: −3.95B JPYNet income, FY2025: 268M JPYFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 2.99B JPY. Revenue FY2022 4.41B JPY. Revenue FY2023 5.01B JPY. Revenue FY2024 5.14B JPY. Revenue FY2025 5.14B JPY. Operating income FY2021 −315.91M JPY. Operating income FY2022 −498.5M JPY. Operating income FY2023 −788.47M JPY. Operating income FY2024 −688.35M JPY. Operating income FY2025 22.94M JPY. Net income FY2021 −410.8M JPY. Net income FY2022 −664.86M JPY. Net income FY2023 −807.18M JPY. Net income FY2024 −3.95B JPY. Net income FY2025 268M JPY.
Metric (JPY)FY2025FY2024FY2023FY2022FY2021
Revenue5.14B JPY5.14B JPY5.01B JPY4.41B JPY2.99B JPY
Cost of goods sold3.35B JPY3.06B JPY3.11B JPY3.23B JPY1.55B JPY
Gross profit1.79B JPY2.07B JPY1.9B JPY1.18B JPY1.44B JPY
Research and development48.75M JPY808M JPY794M JPY662M JPY441M JPY
Selling, general, and administrative1.72B JPY1.95B JPY1.89B JPY1.02B JPY1.32B JPY
Operating expenses1.76B JPY2.76B JPY2.69B JPY1.68B JPY1.76B JPY
Interest income250K JPY140K JPY4K JPY3K JPY3K JPY
Interest expense51.02M JPY28.34M JPY17.42M JPY9.72M JPY3.77M JPY
Depreciation and amortization364.76M JPY771.14M JPY657.27M JPY496.91M JPY179.59M JPY
Operating income22.94M JPY−688.35M JPY−788.47M JPY−498.5M JPY−315.91M JPY
Net income268M JPY−3.95B JPY−807.18M JPY−664.86M JPY−410.8M JPY

Company facts updated Aug 24, 2026.

Earnings

Latest EPS result
-21.59

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly EPS actual values compared with estimates30.2-48.12-126.43-204.75Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 6, 2024: actual -25.2, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 7, 2025: actual -19.93, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 9, 2025: actual -188.55, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 7, 2025: actual -4.39, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 10, 2025: actual -0.27, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 5, 2026: actual 11.78, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 12, 2026: actual 14, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 5, 2026: actual -21.59, estimate —, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Estimates unavailable
Quarterly Revenue actual values compared with estimates1.74B1.45B1.16B868.12MQ4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Q4 2024, reported Nov 6, 2024: actual 1.08B JPY, estimate —, surprise —, Comparison unavailable. Q1 2025, reported Feb 7, 2025: actual 1.1B JPY, estimate —, surprise —, Comparison unavailable. Q2 2025, reported May 9, 2025: actual 1.67B JPY, estimate —, surprise —, Comparison unavailable. Q3 2025, reported Jul 7, 2025: actual 991.16M JPY, estimate —, surprise —, Comparison unavailable. Q4 2025, reported Nov 10, 2025: actual 1.1B JPY, estimate —, surprise —, Comparison unavailable. Q1 2026, reported Feb 5, 2026: actual 1.42B JPY, estimate —, surprise —, Comparison unavailable. Q2 2026, reported May 12, 2026: actual 1.64B JPY, estimate —, surprise —, Comparison unavailable. Q3 2026, reported Aug 5, 2026: actual 935M JPY, estimate —, surprise —, Comparison unavailable.

3628.T peers

Chugai Pharmaceutical Co., Ltd. logo

4519.T

Chugai Pharmaceutical Co., Ltd.

¥7,009

-0.03%

Takeda Pharmaceutical Company Limited logo

4502.T

Takeda Pharmaceutical Company Limited

¥5,814

+0.87%

HOYA Corporation logo

7741.T

HOYA Corporation

¥25,000

+0.42%

Otsuka Holdings Co., Ltd. logo

4578.T

Otsuka Holdings Co., Ltd.

¥12,285

+0.74%

Daiichi Sankyo Company, Limited logo

4568.T

Daiichi Sankyo Company, Limited

¥2,866.5

+1.16%

Astellas Pharma Inc. logo

4503.T

Astellas Pharma Inc.

¥2,396.5

+0.40%

Continue in GoAI

Research 3628.T

research.disclaimer